Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of Echocardiography Artificial Intelligence Models: A Narrative Review.

Journal of clinical medicine·2025
Same author

Nutrient-adequate diets with the lowest greenhouse gas emissions or price are the least acceptable-insights from dietary optimisation modelling using the iOTA model<sup>®</sup>.

Frontiers in nutrition·2025
Same author

Alternative protein-based foods must contribute to micronutrient adequacy.

Journal of the Royal Society of New Zealand·2025
Same author

Analysis of global nutrient gaps and their potential to be closed through redistribution and increased supply.

Frontiers in nutrition·2024
Same author

Artificial intelligence and innovation of clinical care: the need for evidence in the real world.

European heart journal·2023
Same author

Modeling the Contribution of Meat to Global Nutrient Availability.

Frontiers in nutrition·2022
Same journal

Bereaved Parents and Spouses as Educators in Pediatric Simulation: Ethical Reflections.

Journal of pain and symptom management·2026
Same journal

The Unplugged Patient: A Case Report on Bridging the Digital Divide in Palliative Care.

Journal of pain and symptom management·2026
Same journal

Barriers perceived by palliative care fellowships in training physicians from diverse specialties.

Journal of pain and symptom management·2026
Same journal

Health Equity: Foundation of Serious Illness Care.

Journal of pain and symptom management·2026
Same journal

Coping with Breathlessness in Individuals with Lung Diseases: A Systematic Review and Meta-Synthesis.

Journal of pain and symptom management·2026
Same journal

Growing the Next Generation of Hospice and Palliative Medicine Researchers.

Journal of pain and symptom management·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Levomepromazine-induced lupus?

Andrew J Fletcher

    Journal of Pain and Symptom Management
    |June 9, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
    12:04

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

    Published on: November 1, 2015

    Related Experiment Videos

    Last Updated: Jun 22, 2026

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
    09:43

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

    Published on: June 8, 2022

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
    12:04

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

    Published on: November 1, 2015